[144] ANI Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

ANI Pharmaceuticals (ANIP) has a Form 144 notice showing an insider proposes to sell 19,341 common shares, representing the full amount of two restricted stock grants received on 03/23/2022 (9,292 shares) and 04/27/2023 (10,049 shares). The planned sale is listed with an aggregate market value of $1,662,047.56 and an approximate sale date of 08/12/2025 on NASDAQ.

The shares to be sold compare with 21,699,636 shares outstanding, or roughly 0.09% of outstanding stock, and the filer reports no securities sold in the past three months. The filer also certifies they do not possess undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small, clearly documented insider sale of restricted stock totaling $1.66M, representing about 0.09% of shares outstanding.

The Form 144 discloses a planned sale of 19,341 common shares acquired as restricted stock in two tranches (03/23/2022 and 04/27/2023). The stated aggregate market value is $1,662,047.56 with an approximate sale date of 08/12/2025 on NASDAQ. Relative to the 21.7 million shares outstanding, the proposed sale is immaterial in size and does not indicate dilution or a company-level financing event. The filing notes no sales in the past three months, which provides context for timing but does not signal broader distribution activity.

Corporate Governance Expert

TL;DR: Routine insider disposition filing documenting sales of previously issued restricted stock; disclosure appears complete.

The notice identifies the securities as restricted stock originally issued by the company and specifies acquisition dates and amounts, which supports transparency on the source of shares. The filer affirms no material nonpublic information is known. From a governance perspective, the form fulfills Rule 144 disclosure requirements by listing broker details, share counts, and the exchange. The transaction is administrative rather than a governance change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19341	1662047.56	21699636	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2023	Restricted Stock	Issuer			10049	04/27/2023	Not Applicable
Common	03/23/2022	Restricted Stock	Issuer			9292	03/23/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ANIP shares are being proposed for sale in this Form 144?

The Form 144 lists 19,341 common shares proposed for sale.

What is the aggregate market value of the proposed ANIP sale?

The aggregate market value reported is $1,662,047.56.

When is the approximate date of sale for the ANIP shares?

The approximate date of sale listed is 08/12/2025.

What type of ANIP shares are being sold and how were they acquired?

They are common shares acquired as restricted stock on 03/23/2022 (9,292 shares) and 04/27/2023 (10,049 shares).

Does the filing report any ANIP sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

On which exchange will the ANIP shares be sold and who is the broker?

The sale is listed to occur on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.